Vaccine Effectiveness - Beyond COVID-19

Moderator(s)

• 

  Katsiaryna Bykov, PharmD, ScD

  Assistant Professor
  Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
  Boston, United States
• 

  Elizabeth Bell, PhD, MPH (she/her/hers)

  Senior Research Scientist
  Harvard Pilgrim Health Care Institute
  Minneapolis, United States

Presentations:

• 8:30 AM – 8:45 AM CEST

  Hospitalization Risk among Early Adopters of Respiratory Syncytial Virus Vaccines: A Machine Learning Approach
  

  Presenting Author: Michael J. Munsell, PhD – Panalgo

  Co-Author: Mark Friedman, MD – Panalgo

  Co-Author: Joseph Menzin, PhD – Panalgo

  Co-Author: Tiffany S. Siu Woodworth, MPH, MBA – Panalgo
• 8:45 AM – 9:00 AM CEST

  Real-Worl Effectiveness of Maternal Influenza Vaccination During Pregnancy on Risk of Infant Influenza During the First 6 Months of Life
  

  Presenting Author: Ousseny Zerbo, PhD – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA

  Co-Author: Holly Finertie – Division of Research, Kaiser Permanente Northern California, Oakland, California

  Co-Author: Romain Neugebauer – Kaiser Permanente Division of Research; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA

  Co-Author: Kristin S. Goddard, MPH (she/her/hers) – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California

  Co-Author: Nicola P. Klein, MD, PhD – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
• 9:00 AM – 9:15 AM CEST

  Impact of Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Diseases and Antibiotic Prescribing in the United Kingdom
  

  Presenting Author: Lydia E. Gamey – School of Pharmacy, Queen's University Belfast

  Co-Author: Carmel Hughes – School of Pharmacy, Queen's University Belfast

  Co-Author: Wallis Lau, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.

  Co-Author: Boqing Chen, MSc (he/him/his) – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.

  Co-Author: Konstantinos Karampatsas – Centre for Neonatal and Paediatric Infection, St. George’s University of London

  Co-Author: Yingfen Hsia – School of Pharmacy, Queen's University Belfast
• 9:15 AM – 9:30 AM CEST

  Effectiveness of recombinant herpes zoster vaccine by immune status and prior receipt of live zoster vaccine in Medicare enrollees, 2018-2019
  

  Presenting Author: Jonathan Fix, PhD, MSPH (he/him/his) – Novavax

  Co-Author: Nadja A. Vielot, PhD, MSPH (she/her/hers) – University of North Carolina at Chapel Hill

  Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill

  Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill

  Co-Author: David Weber – University of North Carolina at Chapel Hill

  Co-Author: Sylvia Becker-Dreps – University of North Carolina at Chapel Hill

  Co-Author: Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
• 9:30 AM – 9:45 AM CEST

  Antibiotic Exposure and Inactivated Influenza Vaccine Effectiveness
  

  Presenting Author: Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science

  Co-Author: Abner Nyandege, PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science

  Co-Author: Edward Nonnenmache – Bayshore Analytics and Integrated Solutions LLC

  Co-Author: Jason A. Roy, PhD – Rutgers School of Public Health

  Co-Author: Kirk Benack – Montefiore Medical Center

  Co-Author: Saira Jan, MS, Pharm.D. – Horizon Blue Cross Blue Shield of New Jersey

  Co-Author: Soko Setoguchi, MD, DrPH – Rutgers University

  Co-Author: Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research

  Co-Author: Brian L. Strom, MD, MPH (he/him/his) – Rutgers, State University of New Jersey
• 9:45 AM – 10:00 AM CEST

  Effectiveness and Safety of the MVA-BN vaccine against Mpox in at-risk individuals in the United States (USMVAc)
  

  Co-Author: Soowoo Back, MPH – Aetion, Inc

  Co-Author: Bethany Knox, MPH – Aetion, Inc

  Co-Author: Luca Giraldi, PhD, MS – European Medicines Agency (EMA)

  Co-Author: Ciara D. Coakley, MSc – Aetion Germany GmbH

  Co-Author: Nicolas Deltour, MSc – Aetion Germany GmbH

  Co-Author: Emmanuelle Jacquot, MD – Aixial

  Co-Author: Hanaya Raad, MPH – Oracle

  Co-Author: Lorna Leal, MD, PhD – European Medicines Agency (EMA)

  Co-Author: Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency

  Presenting Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.